Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
Clinical trial NCT04819776 · COMPLETED
Trial details
- NCT number
- NCT04819776
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-22
- Primary completion
- 2022-09-07
- Enrollment
- 417
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.